enGene Therapeutics Inc. Common Stock (ENGN) is a publicly traded Healthcare sector company. As of May 21, 2026, ENGN trades at $1.55 with a market cap of $105.17M and a P/E ratio of 0.70. ENGN moved +5.88% today. Year to date, ENGN is -81.56%; over the trailing twelve months it is -61.67%. Its 52-week range spans $1.40 to $12.25. Analyst consensus is buy with an average price target of $8.69. Rallies surfaces ENGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
enGene Therapeutics Inc. Common Stock (ENGN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ENGN moved +5.88% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.55 |
| Market Cap | $105.17M |
| P/E Ratio | 0.70 |
| EPS | $2.29 |
| Dividend Yield | 0.13% |
| 52-Week High | $12.25 |
| 52-Week Low | $1.40 |
| Volume | 1.13K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-117.30M |
| Gross Margin | 0.00% |
12 analysts cover ENGN: 0 strong buy, 4 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.69.